During the past decade, Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "German CLL Study Group" with 3 trials sponsored, "CVRx, Inc." with 2 trials sponsored and "Alector Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator, "Federation Francophone de Cancerologie Digestive" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Arbeitsgruppe Lebermetastasen und Tumoren" with 1 trials as a collaborator and "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch" are "Hypertension" (4 trials), "Sarcoma" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Colorectal Cancer" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch" in a lesser frequency.

Most popular intervention types in "Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch" are "Drug" (17 trials), "Procedure" (7 trials), "Radiation" (5 trials), "Biological" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "radiation therapy" (4 trials), "adjuvant therapy" (3 trials), "conventional surgery" (3 trials) and "fluorouracil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".